Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Teligent
  6. Summary
    TLGT   US87960W2035

TELIGENT

(TLGT)
Delayed OTC Markets  -  09:30:20 2022-07-27 am EDT
0.000200 USD   -.--%
2022Hikma's diversified business delivers resilient H1 performance
AQ
2022Teligent, Inc. Went Out of Business
CI
2022Second Amended Liquidation Plan Approved for Teligent, Inc.
CI
 SummaryQuotesChartsNewsCompanyFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Otc Markets
07/20/2022 07/22/2022 07/25/2022 07/26/2022 07/27/2022 Date
0.0002 0.0002 0.0002 0.0002 0.0002 Last
8607 245 2179 2420 6460 Volume
0.00% 0.00% 0.00% 0.00% 0.00% Change
All news about TELIGENT
2022Hikma's diversified business delivers resilient H1 performance
AQ
2022Teligent, Inc. Went Out of Business
CI
2022Second Amended Liquidation Plan Approved for Teligent, Inc.
CI
2022Second Motion for Exclusivity Period Extension Approved For Teligent, Inc.
CI
2022Second Amended Joint Liquidation Plan Filed by Teligent, Inc.
CI
2022First Amended Disclosure Statement Approved for Teligent, Inc.
CI
2022First Amended Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc.
CI
2022Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc.
CI
2022First Motion for Exclusivity Period Extension Approved For Teligent, Inc.
CI
2022Motion for Case Conversion Filed by Teligent, Inc.
CI
2022First Motion for Exclusivity Period Extension Filed by Teligent, Inc.
CI
2022Hikma Pharmaceuticals Closes $46 Million Purchase of Teligent's Canadian Assets
MT
2022Pharmaceutical Associates, Inc. completed the acqui..
CI
2022Hikma Pharmaceuticals PLC completed the acquisition..
CI
2022Motion for Asset Sale Approved for Teligent, Inc.
CI
More news
News in other languages on TELIGENT
2022Teligent, Inc. a fait faillite
2022Deuxième motion pour la prolongation de la période d'exclusivité approuvée pour Teligen..
2022Première déclaration de divulgation amendée approuvée pour Teligent, Inc.
2022La première demande de prolongation de la période d'exclusivité est approuvée pour Teli..
2022Requête en conversion de cas déposée par Teligent, Inc.
More news
Chart TELIGENT
Duration : Period :
Teligent Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Alyssa Lozynski Chief Financial Officer
John E. Celentano Chairman
Carole S. Ben-Maimon Independent Director
Thomas J. Sabatino Independent Director
Bradley Eric Scher Director